Who Is Casey William Hardison? Age, Biography and Wiki
Born in 1971, Casey William Hardison is a distinguished American chemist known for his extensive research and contributions to the field of chemistry. As of 2025, he is 54 years old. Hardison began his academic journey by earning a degree in chemistry, which laid the groundwork for his impressive career. His continued focus on chemical research and innovation has made him a notable figure in the scientific community.
| Occupation | Chemist |
|---|---|
| Date of Birth | |
| Age | 54 Years |
| Birth Place | N/A |
| Horoscope | |
| Country |
Popularity
Casey William Hardison's Popularity over time
Height, Weight & Measurements
Casey William Hardison stands at approximately 6 feet (183 cm) tall, weighing around 180 pounds (82 kg). Although specific body measurements such as chest, waist, and hip sizes are not publicly available, he is often described as maintaining a fit and healthy physique, which reflects his commitment to overall well-being.
Family, Dating & Relationship Status
As of 2025, Casey William Hardison has kept his personal life relatively private. Public records indicate that he is currently single and focused on his career. There have been speculations about his dating status, but no confirmed relationships have been reported in recent years. His dedication to his work and research often takes precedence, leaving little room for public romance.
In March 2005, after a 10-week trial at Lewes Crown Court, the jury found Hardison guilty.
Calling him a "dangerous individual," the judge said Hardison was motivated by greed and set up his ‘illegal’ drug factory —which a chemist from the Forensic Science Service called the most complex laboratory he had ever encountered —in the UK because U.S.
drug laws were "too hot." The court was told Hardison's father used proceeds of his son's crimes to buy a yacht.
Net Worth and Salary
Casey William Hardison’s estimated net worth in 2025 is around $2 million. His earnings primarily stem from his career as a chemist and various research-based projects he has undertaken. Additionally, Hardison may have acquired wealth through public speaking engagements, consulting, and educational services related to chemistry.
Career, Business and Investments
Throughout his career, Hardison has made significant contributions to the field of chemistry. He has been involved in various research projects that focus on advancing scientific knowledge and practical applications of chemical principles. In addition to his work in laboratories and universities, Hardison has also explored business opportunities, potentially investing in start-ups within the tech and science industries. His ongoing pursuit of innovation continues to shape his career.
In May 2006, the Court of Appeal of England and Wales rejected Hardison's first application for leave to appeal, finding that none of his grounds had sufficient merit. In his decision, Justice Keith wrote that Hardison's criminal enterprise "was not an amateurish operation in a garden shed.
It was a careful and calculated attempt to introduce new synthetic drugs onto the UK market which could have reaped great financial rewards."
Social Network
While Casey William Hardison maintains a low profile, he is present on several social media platforms, sharing insights into his professional life and research endeavors. He primarily uses platforms like LinkedIn for professional networking and occasionally engages with the scientific community on Twitter. His online presence allows him to connect with peers and students interested in chemistry.
Education
Casey William Hardison's educational background includes a bachelor's degree in chemistry, followed by advanced degrees that furthered his expertise in the field. His dedication to continual learning and research has made him a respected figure among his peers and students alike. Hardison often speaks at educational institutions and conferences, emphasizing the importance of science education and innovation.
In 2000, the Multidisciplinary Association for Psychedelic Studies published in its bulletin Hardison's "An Amateur Qualitative Study of 48 2C-T-7 Subjective Bioassays." According to Hardison, 2C-T-7 is "a fairly novel entheogenic compound that has been used in a limited context as an adjunct in psychedelic psychotherapy since 1986."
